Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Perception and communication of life expectancy and prognosis in sickle cell disease: a multi-center study of adolescents with sickle cell disease, their parents and pediatric hematologists
source: The American Society of Pediatric Hematology/Oncology
authors: Lydia H. Pecker, Nicholas Whipple, Julie Krystal, Vera Osafo, Barbara Speller-Brown, Lisa Thaniel, Banu Aygun, Jane S. Hankins, Ellen Silver, Michael Roth, Deepa Manwanisummary/abstract:
Background: Sickle cell disease (SCD) is a heterogenous condition causing substantial morbidity and early mortality, but life expectancy has improved in recent decades. Research shows that affected adolescents/young adults (AYAs) and their parents understand the effect of SCD on their future differently than physicians. How prognosis is addressed in clinical practice is unknown and important for shared, informed decision-making.
Objectives: To compare perceptions of SCD-related prognosis among AYAs, parents and pediatric hematologists.
Design/Method: We conducted surveys to English-speaking AYAs (ages 11 – 21) with SCD, their parents, and pediatric hematologists about prognosis in SCD. AYAs and parents were recruited from four centers during health-maintenance visits. Questions were grouped by theme and answers compared using Chi-square or Fisher’s exact tests.
Results: 101 adolescents, 98 parents and 115 pediatric hematologists completed surveys. Adolescents were 51.5% female, 85% Black, with a mean age of 16.44 +/- 2.6 years; 72.3% had HbSS, 63.5% were taking hydroxyurea. Parents were 77.4% female, 84.4% Black; 73.5% of their children had HbSS, 56.1% were taking hydroxyurea. Parents (67.3%) and AYAs (53.4%) rated discussions of life expectancy as “very important”, however 68% of parents and 57.3% of AYAs reported that their doctors did “not often” discuss how long patients with SCD live. Consistent with this, 37% of doctors reported discussing life expectancy with AYAs; 39% did with parents. Most doctors (77%) reported patients initiating prognostic discussions. AYAs (63%) and parents (50%) want doctors to discuss life expectancy. Most hematologists thought AYAs (98.2%) and parents (89.8%) were somewhat to very afraid of SCD. Parents reported more fear of SCD than adolescents (29.2% vs. 13% “very afraid”, 39.8% vs. 36% “a little afraid”, 30.2 vs. 51% “not afraid,” p<.01). AYAs (50%) and parents (71%) did not believe that SCD would change life expectancy.
Conclusion: Prognostic discussions that include life expectancy are infrequent among AYAs with SCD; AYAs and their parents report wanting this information. Pediatric hematologists perceive that patients and families have more fear of SCD than patients and parents report. This study provides novel information to design interventions to guide conversations regarding disease prognosis and possibly treatment decisions with patients with SCD and their families.read more
Fear, Anger, SCD and #BLACKLIVESMATTERJune 10, 2020 at 6pm Eastern Time Sessi...
Medicaid to Cover Endari for Sickle Cell Disease in the U.S.Emmaus Life Sciences has reached an agre...
Peer-to-Peer Mentoring Program – SCDAAThe goal of the program is to support th...
What You Should Know About Sickle Cell Disease and PregnancyWhat should someone with sickle cell tra...
Dr. Doris Wethers, 91, on Front Lines against Sickle Cell, DiesDr. Doris L. Wethers, who broke racial b...
Dating With Sickle Cell Can Be a Psychologically Damaging AffairOver my years as an adult, I’ve often ...
The Prevalence of Mood and Alcohol Related Disorders within the Adult Sickle Cell Disease Population and Their Impac...Background: Chronic pain, along with the...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.